Ardent Health (NYSE:ARDT) Rating Increased to Hold at BMO Capital Markets

by · The Markets Daily

Ardent Health (NYSE:ARDT – Get Free Report) was upgraded by BMO Capital Markets to a “hold” rating in a report released on Tuesday, Zacks reports.

ARDT has been the subject of a number of other reports. Guggenheim upped their price objective on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Weiss Ratings downgraded Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. Royal Bank Of Canada increased their price target on Ardent Health from $12.00 to $13.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Finally, Leerink Partners restated an “outperform” rating and set a $14.00 price objective on shares of Ardent Health in a research note on Friday, September 18th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $12.79.

Get Our Latest Analysis on Ardent Health

Ardent Health Price Performance

Shares of ARDT stock opened at $10.65 on Tuesday. The company has a market capitalization of $1.50 billion, a PE ratio of 19.37, a price-to-earnings-growth ratio of 3.10 and a beta of 0.71. The firm has a fifty day simple moving average of $10.85 and a 200-day simple moving average of $9.93. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48.

Ardent Health (NYSE:ARDT – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The firm had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities research analysts anticipate that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. WINTON GROUP Ltd acquired a new stake in shares of Ardent Health in the 2nd quarter valued at about $124,000. Integrated Wealth Concepts LLC acquired a new position in Ardent Health in the second quarter worth about $57,000. Allworth Financial LP grew its stake in Ardent Health by 131.3% in the second quarter. Allworth Financial LP now owns 2,863 shares of the company’s stock worth $28,000 after purchasing an additional 1,625 shares in the last quarter. Corient Private Wealth LP bought a new stake in Ardent Health in the second quarter valued at about $159,000. Finally, AXQ Capital LP increased its holdings in Ardent Health by 69.3% in the second quarter. AXQ Capital LP now owns 25,045 shares of the company’s stock valued at $246,000 after buying an additional 10,249 shares during the last quarter.

Ardent Health Company Profile

(Get Free Report)

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.

Read More